Search for: "Johns v. Wyeth Pharmaceuticals Inc, et al"
Results 1 - 10
of 10
Sorted by Relevance
|
Sort by Date
3 Mar 2012, 5:36 pm
Minn. 2008)(noting that some but not all courts have concluded relative risks under two support finding expert witness’s opinion to be inadmissible) XYZ, et al. v. [read post]
18 Mar 2011, 10:04 am
Pharmaceutical Cases Ambrosini v. [read post]
14 Jun 2013, 12:13 pm
Merrell Dow Pharmaceuticals, Inc., 911 F.2d 941, 948 (3d Cir. 1990). [read post]
5 Jun 2013, 5:29 am
Oct. 24, 1996) Merrell Dow Pharms., Inc. v. [read post]
23 Aug 2008, 1:23 am
: (Part 1 - SPICY IP), (Part 2 - SPICY IP) Global – Copyright International Federation of the Phonographic Industry (IFPI): ‘Three strikes’ effort hit worldwide home run: (Ars Technica), How to attribute a Creative Commons licensed work: (Molly Kleinman), Chrysalis disappoints, as new artists fail to incubate: (IP finance), DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) Events 26 August:… [read post]
15 Mar 2010, 2:09 pm
Molina v. [read post]
27 Jun 2008, 10:04 am
: (The Invent Blog), Impressive work on history of ‘Happy Birthday’ and copyright protection: (Innovationpartners), Gender and copyright: (Patry Copyright Blog) Events 1 July: US PLI: ‘Prior art & obviousness 2008: The PTO and CAFC perspective on patent law sections 102 & 103’ - New York: (Patent Docs), 1-2 July – C5 conference on intellectual asset management for high-tech industries – Paris: (c5-online.com), 2… [read post]
15 Mar 2008, 7:00 am
India: Gene silencing: (Spicy IP), India: US Patent reform implications for Indian Pharma: (Spicy IP), India: Generic pharmaceutical industry in the spotlight: (International Law Office), India: Supreme Court refuses to stay a Gujarat High Court decision restraining Ranbaxy from airing its controversial ads directed against Paras Pharma's 'Moov' brand: (Spicy IP),India: Patents on ARV drugs could increase costs: (Generic Pharmaceuticals & IP),US: Survey… [read post]
25 Apr 2015, 11:03 am
., citing Ofer Shpilberg, et al., The Next Stage: Molecular Epidemiology, 50 J. [read post]
15 Feb 2008, 9:00 am
A step behind: (Spicy IP),Proposals for ISPs to terminate infringers go (even more) global: (LawFont.com),Five ways to minimize risk of copyright liability from citizen media: (IP ADR Blog), Pharma & BiotechPharma & Biotech - GeneralMillennium Pharmaceuticals spent $1.28 million on lobbying for patent reform and biologics legislation in 2007: (Patent Docs),New Thai Minister may review compulsory licences on cancer drugs: (Intellectual Property… [read post]
